| Literature DB >> 28523101 |
Hirofumi Nakano1, Tsukasa Hasegawa1, Hirotatsu Kojima1, Takayoshi Okabe1, Tetsuo Nagano1.
Abstract
In the development of kinase inhibitors, one of the major concerns is selectivity. An effective strategy to achieve high selectivity is to utilize structural differences among kinases to inform inhibitor design. Here, we set out to improve the PIM (proviral integration site for Moloney murine leukemia virus) kinase-inhibitory selectivity of our previously reported 7-azaindole derivative 2, which has promising ADMET properties, by targeting a unique bulge in the ATP-binding pocket. 6-Substituted 7-azaindoles, especially the 6-chlorinated derivatives, proved to be potent and selective PIM kinase inhibitors and appear to be promising lead compounds for future drug discovery.Entities:
Keywords: ADMET; PIM kinase; kinase inhibitor; kinase selectivity; structure−based drug design
Year: 2017 PMID: 28523101 PMCID: PMC5430388 DOI: 10.1021/acsmedchemlett.6b00518
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345